.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Accenture
Healthtrust
Federal Trade Commission
Moodys
Mallinckrodt
Deloitte
McKinsey
Cerilliant
Covington

Generated: September 24, 2017

DrugPatentWatch Database Preview

ZEBETA Drug Profile

« Back to Dashboard

Which patents cover Zebeta, and when can generic versions of Zebeta launch?

Zebeta is a drug marketed by Teva Womens and is included in one NDA.

The generic ingredient in ZEBETA is bisoprolol fumarate. There are twelve drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the bisoprolol fumarate profile page.

Summary for Tradename: ZEBETA

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list119
Clinical Trials: see list3
Patent Applications: see list3,649
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ZEBETA at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Womens
ZEBETA
bisoprolol fumarate
TABLET;ORAL019982-002Jul 31, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Womens
ZEBETA
bisoprolol fumarate
TABLET;ORAL019982-001Jul 31, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ZEBETA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Womens
ZEBETA
bisoprolol fumarate
TABLET;ORAL019982-002Jul 31, 1992► Subscribe► Subscribe
Teva Womens
ZEBETA
bisoprolol fumarate
TABLET;ORAL019982-001Jul 31, 1992► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
US Department of Justice
Citi
Merck
Argus Health
McKinsey
Healthtrust
Harvard Business School
Federal Trade Commission
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot